Clinical Trial

HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis

Name: HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis — clinical trial record (NCT07629778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter Phase Ib/II clinical study designed to evaluate the efficacy, safety, and PK characteristics of HL-300 ointment with different concentration regimens for mild-to-moderate AD.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-24

Trial Details

NCT Number	NCT07629778
Lead Sponsor	Hangzhou Highlightll Pharmaceutical Co., Ltd
Conditions	Atopic Dermatitis
Enrollment	156 participants
Start Date	2026-05-26
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-23